Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 2008

View Archived Issues

Recent patents divulge new anticancer agents

New therapeutics for psychiatric disorders described in recent patent literature

European launch for OncoVAX slated for June

Lpath outlines objectives for 2008

Demerger proposal for Photocure and PCI Biotech

Living Cell Technologies and Barbara Davis Center to collaborate on diabetes clinical trial program

Recent patents disclose novel treatment options for cardiovascular disorders

Positive preclinical results for TG-100801 in murine models of CNV

Angiogenesis inhibition by iCo-007 effective in diabetic macular edema

Medivir reports Q4 and full-year 2007 results

Arriva initiates phase IIb development of late-stage inhaled protein rAAT following financing

Savient reports further information regarding the negative results in phase III trials of Puricase

Pharmacyclics reports clinical development plans for promising product candidates

Kosan presents an update on its clinical portfolio priorities

Galapagos updates clinical plans for rheumatoid arthritis candidate and other programs

Hutchison MediPharma initiates phase IIb clinical trial of HMPL-004 in ulcerative colitis

Intercell presents an update on development of its Japanese encephalitis vaccine

FDA approves supplemental NDA for Abilify in pediatric bipolar disorder

FDA grants priority review for Aciphex sNDA for GERD in adolescents

NicOx initiates two studies for naproxcinod in hypertensive osteoarthritis patients

Dong-A's DA-6034 potentially useful in dry eye syndrome

Trophos awarded EUR 1 million grant for TRO-40303 in ischemia-reperfusion injury

BIX provides neuroprotection against ER stress

Actelion and Nippon Shinyaku enter agreement for prostaglandin I2 receptor agonist NS-304

Chugai files Japanese application for Xeloda combination therapy

Meta-analysis focused on baseline severity casts doubt on SSRI antidepressant efficacy

Cell Therapeutics submits MAA to the EMEA for Xyotax in non-small cell lung cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...